✦ LIBER ✦

Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy

✍ Scribed by Yoon, Se-Jung; Yoon, Young Won; Lee, Byoung Kwon; Kwon, Hyuck Moon; Hwang, Ki-Chul; Kim, Myunghyun; Chang, Woochul; Hong, Bum-Kee; Lee, Young-Ho; Park, Soon-Jung; Min, Pil-Ki; Rim, Se-Joong

Book ID: 120835117
Publisher: Korean Society of Medical Biochemistry and Molecular Biology
Year: 2009
Tongue: English
Weight: 543 KB
Volume: 41
Category: Article
ISSN: 1226-3613
DOI: 10.3858/emm.2009.41.11.086

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HMG-CoA reductase inhibitor enhances ind

HMG-CoA reductase inhibitor enhances inducible nitric oxide synthase expression in rat vascular smooth muscle cells; involvement of the Rho/Rho kinase pathway

✍ Teruyuki Yamamoto; Kazuo Takeda; Sanae Harada; Tetsuo Nakata; Akihiro Azuma; Sus 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 391 KB

POSSIBLE ROLE OF STATIN ON THE OXIDATIVE

POSSIBLE ROLE OF STATIN ON THE OXIDATIVE STRESS INDUCED BY ADVANCED GLYCATION END PRODUCT (AGE) IN VSMC OF DIABETIC VASCULOPATHY

✍ Yoon, S.; Yoon, Y.; Hwang, K.; Chang, W.; Kwon, H.; Hong, B.; Rim, S.; Kim, H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

W13-P-026 The potential role of advanced

W13-P-026 The potential role of advanced glycation end products (AGEs) in vascular smooth muscle cell proliferation and restenosis in diabetic vasculopathy

✍ Yoon, Y.W.; Kwon, H.M.; Hwang, K.C.; Choi, E.Y.; Hong, B.K.; Kim, D.S.; Kim, H.S 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 287 KB

24 HMG-CoA reductase inhibition by atorv

24 HMG-CoA reductase inhibition by atorvastatin (ATV) induces apoptosis of vascular smooth muscle cells (VSMC) in culture—role of isoprenoids of the mevalonate pathway

✍ C. Guijarro; M. Ortego; A. Ortiz; M.A. Hernández-Presa; C. Bustos; C. Diaz; G. H 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 185 KB

The HMG-CoA reductase inhibitor rosuvast

The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

✍ A. C. Calkin; S. Giunti; K. J. Sheehy; C. Chew; V. Boolell; Y. S. Rajaram; M. E. 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 420 KB